Series introduction: the molecular and physiological basis of insulin resistance: emerging implications for metabolic and cardiovascular diseases.
about
The Role of Organelle Stresses in Diabetes Mellitus and Obesity: Implication for Treatmentβ-Cell failure in type 2 diabetes.Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndromeMulti-tissue computational modeling analyzes pathophysiology of type 2 diabetes in MKR mice.A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular diseaseβ-cell function is associated with metabolic syndrome in Mexican subjects.Insulin: in search of a syndrome.Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses.Fatty acids and the metabolic syndrome.Therapeutic perspectives of adipocytokines.The metabolic syndrome: the crossroads of diet and genetics.Skeletal intramyocellular lipid metabolism and insulin resistance.Adipokines and hepatic insulin resistanceRevisiting the diacylglycerol-induced insulin resistance hypothesis.Diabetes treatment in 2025: can scientific advances keep pace with prevalence?Chronic rosiglitazone treatment restores AMPKalpha2 activity in insulin-resistant rat skeletal muscle.Angiographic characteristics of the coronary artery in patients with type 2 diabetes.Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes.Isoproterenol inhibits resistin gene expression through a G(S)-protein-coupled pathway in 3T3-L1 adipocytes.The transcription factor SREBP-1c is instrumental in the development of beta-cell dysfunction.Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice.The relationship of insulin resistance with SNP 276G>T at adiponectin gene and plasma long-chain polyunsaturated fatty acids in obese children.Combination of Vildagliptin and Pioglitazone in Experimental Type 2 Diabetes in Male Rats.3-Keto-1,5-bisphosphonates Alleviate Serum-Oxidative Stress in the High-fat Diet Induced Obesity in Rats.PPAR-gamma2 Pro12Ala variant, insulin resistance and plasma long-chain polyunsaturated fatty acids in childhood obesity.Muscle glycogen content in type 2 diabetes mellitus.Silymarin improved diet-induced liver damage and insulin resistance by decreasing inflammation in mice.Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan.Age-dependent onset of liver-specific IGF-I gene deficiency and its persistence in old age: implications for postnatal growth and insulin resistance in LID mice.
P2860
Q26776377-6DA64E9B-4B6D-462E-BB1A-0E13B8F94A7CQ33588325-8A8303CE-A6BD-4DC2-9729-BA7EA2E4AE97Q33902018-83B95E34-24D3-4EDA-BF87-FC57D83D3981Q33910761-804D7740-496B-455B-AACA-D5458BDCC576Q34565501-51625FDC-0C41-4534-8B85-A9B5CF2305DAQ34620434-6882A99E-443F-4161-B287-5AC96C94B2FEQ34808448-67D02640-DBCD-4435-8815-32AB5479D340Q35227175-B7FE0395-11A3-4D63-8E57-CE478C9A1AACQ35538766-1F784FE9-2A96-40D6-9836-F7BB69A15118Q35873155-1D1FCB80-32F2-4AA2-A184-3F55A2C1B2C3Q36118732-A870946E-1353-41F7-A6CC-7DA935E0F965Q36161243-C7C76EDE-DF70-41AF-9561-B5C9E6ADA0C9Q36209848-D89AC8A5-5945-492B-A507-B4A968DCD3DCQ36603044-CBA26AA4-1178-4417-9DED-39255C7DB889Q36896425-261C7376-803B-4B4D-A4A5-3B0833239172Q38056229-19EAAE3A-EC96-487C-8CF3-3DDA055BE423Q39513531-118069CA-EFC9-4CF5-AFF9-93BCB0706FB8Q40381962-70F03172-2E56-423F-B538-F9601B5838A2Q40671149-CE3EC362-4A4E-456E-8FEE-44F77E80E74EQ42804335-13DE08D6-979C-494E-9DB6-4E50EC93ED2CQ42827465-AAC29898-8168-44B7-A3C2-76C5F3CCF752Q44324677-4AC35FAD-D1EA-4DF0-8F94-20B207849109Q44804017-D2851442-1F1E-4960-8921-38A5C7A237A5Q45960301-7726F57A-3D65-445C-8DAA-232B169CBE35Q46475564-0CAB3A65-B4BE-49F4-9311-E999DC5771ADQ46801551-0B458905-90DC-48B8-AF41-BE9FF923B13DQ51491070-48C8D6FC-A081-481C-9689-8031CE0BAD62Q51529037-996812FE-C361-43BD-9093-FBC05EBF1B37Q53778370-D2DA34EF-4E1E-4CC3-B72F-A91D9E0E0C14Q53826109-9A252204-F3E1-48FF-B1D3-68B615A1C8D6Q53864041-D777DB63-A5BD-4AE5-9546-EA4F940DF6D9
P2860
Series introduction: the molecular and physiological basis of insulin resistance: emerging implications for metabolic and cardiovascular diseases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Series introduction: the molec ...... c and cardiovascular diseases.
@ast
Series introduction: the molec ...... c and cardiovascular diseases.
@en
type
label
Series introduction: the molec ...... c and cardiovascular diseases.
@ast
Series introduction: the molec ...... c and cardiovascular diseases.
@en
prefLabel
Series introduction: the molec ...... c and cardiovascular diseases.
@ast
Series introduction: the molec ...... c and cardiovascular diseases.
@en
P2860
P356
P1476
Series introduction: the molec ...... c and cardiovascular diseases.
@en
P2093
A R Saltiel
P2860
P304
P356
10.1172/JCI10533
P407
P577
2000-07-01T00:00:00Z